- Home
- AEE vs WST Comparison
AEE vs WST Comparison
Compare AEE & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEE
- WST
- Stock Information
- Founded
- AEE 1901
- WST 1923
- Country
- AEE United States
- WST United States
- Employees
- AEE N/A
- WST N/A
- Industry
- AEE Power Generation
- WST Medical/Dental Instruments
- Sector
- AEE Utilities
- WST Health Care
- Exchange
- AEE Nasdaq
- WST Nasdaq
- Market Cap
- AEE 26.0B
- WST 15.6B
- IPO Year
- AEE N/A
- WST N/A
- Fundamental
- Price
- AEE $96.53
- WST $227.12
- Analyst Decision
- AEE Buy
- WST Buy
- Analyst Count
- AEE 11
- WST 7
- Target Price
- AEE $100.91
- WST $331.67
- AVG Volume (30 Days)
- AEE 1.7M
- WST 646.1K
- Earning Date
- AEE 07-31-2025
- WST 07-24-2025
- Dividend Yield
- AEE 2.95%
- WST 0.37%
- EPS Growth
- AEE 3.54
- WST N/A
- EPS
- AEE 4.51
- WST 6.37
- Revenue
- AEE $7,596,000,000.00
- WST $2,895,800,000.00
- Revenue This Year
- AEE $13.04
- WST $3.38
- Revenue Next Year
- AEE $5.42
- WST $5.85
- P/E Ratio
- AEE $21.36
- WST $35.63
- Revenue Growth
- AEE 9.04
- WST N/A
- 52 Week Low
- AEE $71.87
- WST $187.43
- 52 Week High
- AEE $104.10
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- AEE 51.36
- WST 59.84
- Support Level
- AEE $94.20
- WST $219.60
- Resistance Level
- AEE $96.46
- WST $233.84
- Average True Range (ATR)
- AEE 1.27
- WST 5.29
- MACD
- AEE 0.11
- WST 0.60
- Stochastic Oscillator
- AEE 74.71
- WST 66.82
About AEE Ameren Corporation
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas in Missouri and Illinois. It serves 2.5 million electricity customers and approximately 1 million natural gas customers.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.